Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 254-261 , October 2004

Musculoskeletal system

  • Hossein Jadvar, MD, PhD

      Affiliations

    • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
    • Corresponding Author InformationAddress reprint requests to: H. Jadvar, MD, PhD, Assistant Professor of Radiology and Biomedical Engineering, Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine, University of Southern California, 1200 N. State Street, GNH 5250, Los Angeles, CA 90033.
    • ,
  • Sherief Gamie, MD

      Affiliations

    • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
    • ,
  • Lalitha Ramanna, MD

      Affiliations

    • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
    • ,
  • Peter S. Conti, MD, PhD

      Affiliations

    • Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA.

References 

  1. National Cancer Institute Surveillance, Epidemiology, and End Results (NCI-SEER) Program . http://seer.cancer.gov 2003;
  2. Conti PS , Lilien DL , Grafton ST , et al.   PET and [18F]-FDG (A clinical update) . Nucl Med Biol . 1996;23:717–735
  3. Hicks RJ . Nuclear medicine techniques provide unique physiologic characterization of suspected and known soft tissue and bone sarcomas . Acta Orthop Scand Suppl . 1997;273:25–36
  4. Varma DG . Imaging of soft-tissue sarcomas . Curr Oncol Rep . 2000;2:487–490
  5. Mankin HJ , Willett CG , Harmon DC . Malignant tumors of bone . In:  Holleb AI ,  Fink DJ ,  Murphy GP editor. Clinical Oncology . Atlanta, GA: American Cancer Society; 1991;p. 355–358
  6. Jaramillo D , Laor T , Gebhardt M . Pediatric musculoskeletal neoplasms. Evaluation with MR imaging . MRI Clin North Am . 1996;4:1–22
  7. Erlemann R , Sciuk J , Bosse A , et al.   Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy (Assessment with dynamic and static MR imaging and skeletal scintigraphy) . Radiology . 1990;175:791–796
  8. Holscher HC , Bloem JL , Vanel D , et al.   Osteosarcoma (Chemotherapy-induced changes at MR imaging) . Radiology . 1992;182:839–844
  9. Ramanna L , Waxman A , Binney G , et al.   Thallium-201 scintigraphy in bone sarcoma (Comparison with gallium-67 and technetium-99m MDP in the evaluation of chemotherapeutic response) . J Nucl Med . 1990;31:567–572
  10. Menendez LR , Fideler BM , Mirra J . Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma . J Bone Joint Surg . 1993;75:526–531
  11. Kostakoglu L , Panicek DM , Divgi CR , et al.   Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas . Eur J Nucl Med . 1995;22:1232–1237
  12. Abdel-Dayem HM . The role of nuclear medicine in primary bone and soft tissue tumors . Semin Nucl Med . 1997;27:355–363
  13. Caner B , Kitapel M , Unlu M , et al.   Technetium-99m-MIBI uptake in benign and malignant bone lesions (a comparative study with technetium-99m-MDP) . J Nucl Med . 1992;33:319–324
  14. Garcia R , Kim EE , Wong FC , et al.   Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas . J Nucl Med . 1996;37:1476–1479
  15. Aoki J , Inoue T , Tomiyoshi K , et al.   Nuclear imaging of bone tumors (FDG-PET) . Semin Musculoskelet Radiol . 2001;5:183–187
  16. Brenner W , Bohuslavizki KH , Eary JF . PET imaging of osteosarcoma . J Nucl Med . 2003;44:930–942
  17. Schulte M , Brecht-Krauss D , Heymer B , et al.   Fluorodeoxyglucose positron emission tomography of soft tissue tumours (Is a non-invasive determination of biological activity possible?) . Eur J Nucl Med . 1999;26:599–605
  18. Aoki J , Watanabe H , Shinozaki T , et al.   FDG PET of primary benign and malignant bone tumors (standardized uptake value in 52 lesions) . Radiology . 2001;219:774–777
  19. Folpe AL , Lyles RH , Sprouse JT , et al.   (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma . Clin Cancer Res . 2000;6:1279–1287
  20. Hain SF , O’Doherty MJ , Lucas JD , et al.   Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma . Nucl Med Commun . 1999;20:845–848
  21. Tse N , Hoh C , Hawkins R , et al.   Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma . Am J Clin Oncol . 1994;17:22–25
  22. Franzius C , Daldrup-Link HE , Sciuk J , et al.   FDG-PET for detection of pulmonary metastases from malignant primary bone tumors (comparison with spiral CT) . Ann Oncol . 2001;12:479–486
  23. Franzius C , Sciuk J , Daldrup-Link HE , et al.   FDG-PET for detection of osseous metastases from malignant primary bone tumors (comparison with bone scintigraphy) . Eur J Nucl Med . 2000;27:1305–1311
  24. Schulte M , Brecht-Krauss D , Werner M , et al.   Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET . J Nucl Med . 1999;40:1637–1643
  25. Franzius C , Sciuk J , Brinkschmidt C , et al.   Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis . Clin Nucl Med . 2000;25:874–881
  26. Nair N , Ali A , Green AA , et al.   Response of osteosarcoma to chemotherapy. Evaluation with F-18 FDG-PET scans . Clin Positron Imaging . 2000;3:79–83
  27. Hawkins DS , Rajendran JG , Conrad EU , et al.   Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography . Cancer . 2002;94:3277–3284
  28. Franzius C , Bielack S , Flege S , et al.   Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma . J Nucl Med . 2002;43:1012–1017
  29. Page RL , Garg PK , Garg S , et al.   PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment . J Nucl Med . 1994;35:1506–1513
  30. Hoh CK , Hawkins RA , Dahlbom M , et al.   Whole body skeletal imaging with [18F]fluoride ion and PET . J Comput Assist Tomogr . 1993;17:34–41
  31. Posner MC , Brennan MF . Soft tissue sarcomas . In:  Holleb AI ,  Fink DJ ,  Murphy GP editor. Clinical Oncology . Atlanta, GA: American Cancer Society; 1991;p. 359–376
  32. Kern KA , Brunetti A , Norton JA , et al.   Metabolic imaging of human extremity musculoskeletal tumors by PET . J Nucl Med . 1988;29:181–186
  33. Podoloff DA . The role of radionuclide scans in sarcoma . Hematol Oncol Clin North Am . 1995;9:605–626
  34. Miraldi F , Adler LP , Faulhaber P . PET imaging in soft tissue sarcomas . Cancer Treat Res . 1997;91:51–64
  35. Eary JF , Conrad EU , Bruckner JD , et al.   Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma . Clin Cancer Res . 1998;4:1215–1220
  36. Watanabe H , Shinozaki T , Yanagawa T , et al.   Glucose metabolic analysis of musculoskeletal tumors using 18fluorine-FDG PET as an aid to preoperative planning . J Bone Joint Surg Br . 2000;82:760–767
  37. Israel-Mardirosian N , Adler LP . Positron emission tomography of soft tissue sarcomas . Curr Opin Oncol . 2003;15:327–330
  38. Feldman F , van Heertum R , Manos C . 18FDG PET scanning of benign and malignant musculoskeletal lesions . Skeletal Radiol . 2003;32:201–208
  39. Adler LP , Blair HF , Williams RP , et al.   Grading liposarcomas with PET using [18F]FDG . J Comput Assist Tomogr . 1990;14:960–962
  40. Kosuda S , Wahl RL , Grossman HB . Demonstration of recurrent dedifferentiated liposarcoma of the spermatic cord by FDG-PET . Ann Nucl Med . 1997;11:263–266
  41. Aoki J , Watanabe H , Shinozaki T , et al.   FDG-PET in differential diagnosis and grading of chondrosarcomas . J Comput Assist Tomogr . 1999;23:603–608
  42. Thurer RL , Thorsen A , Parker JA , et al.   FDG imaging of a pulmonary artery sarcoma . Ann Thorac Surg . 2000;70:1414–1415
  43. Jadvar H , Fischman AJ . Evaluation of rare tumors with [F-18]-fluorodeoxyglucose positron emission tomography . Clin Positron Imaging . 1999;2:153–158
  44. Aoki J , Endo K , Watanabe H , et al.   FDG-PET for evaluating musculoskeletal tumors (A review) . J Orthop Sci . 2003;8:435–441
  45. Hegner B , Krakamp B , Hedde JP , et al.   Positron emission tomography reveals a leiomyosarcoma causing proteinuria . Clin Nephrol . 2003;60:139–142
  46. Kim JH , Gutierrez FR , Lee EY , et al.   Primary leiomyosarcoma of the pulmonary artery (a diagnostic dilemma) . Clin Imaging . 2003;27:206–211
  47. Ben Arush MW , Israel O , Kedar Z , et al.   Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography (case report) . Pediatr Hematol Oncol . 2001;18:295–298
  48. Schwarzbach MH , Dimitrakopoulou-Strauss A , Mechtersheimer G , et al.   Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET) . Anticancer Res . 2001;21:3609–3614
  49. Stroobants S , Goeminne J , Seegers M , et al.   18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec) . Eur J Cancer . 2003;39:2012–2020
  50. Freudenberg LS , Rosenbaum SJ , Schulte-Herbruggen J , et al.   Diagnosis of a cardiac angiosarcoma by fluorine-18 fluordeoxyglucose positron emission tomography . Eur Radiol . 2002;12(suppl 3):S158–S161
  51. Hain SF , O’Doherty MJ , Bingham J , et al.   Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumors? . Nucl Med Commun . 2003;24:1139–1143
  52. Lucas JD , O’Doherty MJ , Cronin BF , et al.   Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography . Br J Surg . 1999;86:550–556
  53. Lucas JD , O’Doherty MJ , Wong JC , et al.   Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas . J Bone Joint Surg Br . 1998;80:441–447
  54. Bastiaannet E , Groen H , Jager PL , et al.   The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; A systematic review and meta-analysis . Cancer Treat Rev . 2004;30:83–101
  55. Ioannidis JP , Lau J . 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma (A meta-analysis) . J Nucl Med . 2003;44:717–724
  56. Schwarzbach MH , Dimitrakopoulou-Strauss A , Willeke F , et al.   Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas . Ann Surg . 2000;231:380–386
  57. Nieweg OE , Pruim J , van Ginkel RJ , et al.   Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma . J Nucl Med . 1996;37:257–261
  58. Eary JF , Mankoff DA . Tumor metabolic rates in sarcoma using FDG PET . J Nucl Med . 1998;39:250–254
  59. Dimitrakopoulou-Strauss A , Strauss LG , Schwarzbach M , et al.   Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas (impact on diagnosis and correlation with grading) . J Nucl Med . 2001;42:713–720
  60. Lodge MA , Lucas JD , Marsden PK , et al.   A PET study of 18FDG uptake in soft tissue masses . Eur J Nucl Med . 1999;26:22–30
  61. van Ginkel RJ , Hoekstra HJ , Pruim J , et al.   FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma . J Nucl Med . 1996;37:984–990
  62. Conti PS , Menedez LR , Ramanna L , et al.   Use of positron emission tomography in the evaluation of cryosurgical treatment of musculoskeletal tumors . Radiology . 1999;213:118
  63. Vernon CB , Eary JF , Rubin BP , et al.   FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma . Skeletal Radiol . 2003;32:139–142
  64. Van den Abbeele AD , Badawi RD . Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs) . Eur J Cancer . 2002;38(suppl 5):S60–S65
  65. Antoch G , Kanja J , Bauer S , et al.   Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors . J Nucl Med . 2004;45:357–365
  66. Gayed I , Vu T , Iyer R , et al.   The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors . J Nucl Med . 2004;45:17–21
  67. Bredella MA , Caputo GR , Steinbach LS . Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas . Am J Roentgenol . 2002;179:1145–1150
  68. Jones DN , McCowage GB , Sostman HD , et al.   Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET . J Nucl Med . 1996;37:1438–1444
  69. Kole AC , Nieweg OE , van Ginkel RJ , et al.   Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose . Ann Surg Oncol . 1997;4:57–63
  70. el-Zeftawy H , Heiba SI , Jana S , et al.   Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma . Cancer Biother Radiopharm . 2001;16:37–46
  71. Eary JF , O’Sullivan F , Powitan Y , et al.   Sarcoma tumor FDG uptake measured by PET and patient outcome (A retrospective analysis) . Eur J Nucl Med Mol Imaging . 2002;29:1149–1154
  72. Yanagawa T , Watanabe H , Inoue T , et al.   Carbon-11 choline positron emission tomography in musculoskeletal tumors (Comparison with fluorine-18 fluorodeoxyglucose positron emission tomography) . J Comput Assist Tomogr . 2003;27:175–182
  73. Schwarzbach M , Willeke F , Dimitrakopoulou-Strauss A , et al.   Functional imaging and detection of local recurrence in soft tissue sarcomas by positron emission tomography . Anticancer Res . 1999;19:1343–1349
  74. Franzius C , Schulte M , Hillmann A , et al.   Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference “PET in Oncology”: Results of the Bone and Soft Tissue Study Group . Chirurg . 2001;72:1071–1077

PII: S0001-2998(04)00040-6

doi: 10.1053/j.semnuclmed.2004.06.002

Seminars in Nuclear Medicine
Volume 34, Issue 4 , Pages 254-261 , October 2004

Article Tools

* Image Usage & Resolution